6.
Dieu-Nosjean M, Antoine M, Danel C, Heudes D, Wislez M, Poulot V
. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008; 26(27):4410-7.
DOI: 10.1200/JCO.2007.15.0284.
View
7.
Pipi E, Nayar S, Gardner D, Colafrancesco S, Smith C, Barone F
. Tertiary Lymphoid Structures: Autoimmunity Goes Local. Front Immunol. 2018; 9:1952.
PMC: 6143705.
DOI: 10.3389/fimmu.2018.01952.
View
8.
Mikulski Z, Johnson R, Shaked I, Kim G, Nowyhed H, Goodman W
. SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration. Gastroenterology. 2015; 148(4):783-793.e5.
PMC: 4375031.
DOI: 10.1053/j.gastro.2015.01.027.
View
9.
Lewis K, Reizis B
. Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spring Harb Perspect Biol. 2012; 4(8):a007401.
PMC: 3405856.
DOI: 10.1101/cshperspect.a007401.
View
10.
Pikor N, Astarita J, Summers-Deluca L, Galicia G, Qu J, Ward L
. Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation. Immunity. 2015; 43(6):1160-73.
DOI: 10.1016/j.immuni.2015.11.010.
View
11.
Ng K, Boumelha J, Enfield K, Almagro J, Cha H, Pich O
. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature. 2023; 616(7957):563-573.
PMC: 10115647.
DOI: 10.1038/s41586-023-05771-9.
View
12.
Dunne M, Phelan J, Michielsen A, Maguire A, Dunne C, Martin P
. Characterising the prognostic potential of HLA-DR during colorectal cancer development. Cancer Immunol Immunother. 2020; 69(8):1577-1588.
PMC: 7347515.
DOI: 10.1007/s00262-020-02571-2.
View
13.
Thaunat O, Kerjaschki D, Nicoletti A
. Is defective lymphatic drainage a trigger for lymphoid neogenesis?. Trends Immunol. 2006; 27(10):441-5.
DOI: 10.1016/j.it.2006.08.003.
View
14.
Vacchelli E, Ma Y, Baracco E, Sistigu A, Enot D, Pietrocola F
. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science. 2015; 350(6263):972-8.
DOI: 10.1126/science.aad0779.
View
15.
Meric-Bernstam F, Sweis R, Kasper S, Hamid O, Bhatia S, Dummer R
. Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study. Clin Cancer Res. 2022; 29(1):110-121.
PMC: 11188043.
DOI: 10.1158/1078-0432.CCR-22-2235.
View
16.
MKoma A
. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointest Disord (Basel). 2023; 1(1):75-105.
PMC: 10416806.
DOI: 10.3390/gidisord1010007.
View
17.
Gago da Graca C, van Baarsen L, Mebius R
. Tertiary Lymphoid Structures: Diversity in Their Development, Composition, and Role. J Immunol. 2021; 206(2):273-281.
DOI: 10.4049/jimmunol.2000873.
View
18.
GeurtsvanKessel C, Willart M, Bergen I, van Rijt L, Muskens F, Elewaut D
. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med. 2009; 206(11):2339-49.
PMC: 2768850.
DOI: 10.1084/jem.20090410.
View
19.
Devi-Marulkar P, Fastenackels S, Karapentiantz P, Goc J, Germain C, Kaplon H
. Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC. Commun Biol. 2022; 5(1):1416.
PMC: 9789959.
DOI: 10.1038/s42003-022-04356-y.
View
20.
Ahluwalia B, Moraes L, Magnusson M, Ohman L
. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018; 53(4):379-389.
DOI: 10.1080/00365521.2018.1447597.
View